title: Glucose transporter-1 expression and prognostic significance in pancreatic carcinogenesis.
abstract: The purposes of this study were to evaluate the prognostic significance of Glut-1 expression in patients with pancreatic ductal adenocarcinoma, and to analyse its expression in pancreatic intraepithelial neoplasias (PanIN) and non invasive intraductal papillary mucinous neoplasms (IPMN). Glut-1 expression was studied by immunohistochemistry in 60 pancreatic ductal adenocarcinomas and scored on a 4-point scale (1: <25%; 2: 25-50%; 3: 50-75%; 4: >75%). Relationships between Glut-1 score, histological grade and MIB-1 score were evaluated by the Spearman rank correlation test. Significant correlations were found between Glut-1 expression and histological grade (P<0.001) and MIB-1 score (P<0.01). Significant prognostic factors by univariate analysis were stage (P<0.0001), histological grade (P<0.001) and Glut-1 expression (P<0.005). Independent prognostic factors after multivariate analysis were stage (P<0.001) and Glut-1 expression (P<0.05), stratified as <50% and >50%. The correlation of Glut-1 score with histological grade and MIB-1 score indicated a higher glucose uptake in poorly differentiated and highly proliferative pancreatic cancer cells. Glut-1 immunohistochemical expression provides a useful prognostic factor in pancreatic ductal adenocarcinoma. Glut-1 expression was not found in PanINs 1 but in 27.8% and 43.8% of PanINs 2 and 3, and was not found in IPMNs with low- and moderate-grade dysplasia but in 60% of IPMNs with high-grade dysplasia, indicating Glut-1 involvement in a relatively early phase of pancreatic carcinogenesis.
authors.affiliation: Department of Medical Diagnostic Sciences and Special Therapies, University of Padova, Padova, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Pizzi
authors.forename: Andrea
authors.initials: A
authors.lastname: Porzionato
authors.forename: Claudio
authors.initials: C
authors.lastname: Pasquali
authors.forename: Diego
authors.initials: D
authors.lastname: Guidolin
authors.forename: Cosino
authors.initials: C
authors.lastname: Sperti
authors.forename: Paola
authors.initials: P
authors.lastname: Fogar
authors.forename: Veronica
authors.initials: V
authors.lastname: Macchi
authors.forename: Raffaele
authors.initials: R
authors.lastname: De Caro
authors.forename: Sergio
authors.initials: S
authors.lastname: Pedrazzoli
authors.forename: Anna
authors.initials: A
authors.lastname: Parenti
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D021441:Carcinoma, Pancreatic Ductal / Q000378:metabolism*; D049109:Cell Proliferation; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D051272:Glucose Transporter Type 1 / Q000096:biosynthesis* / Q000502:physiology; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000378:metabolism*; D011379:Prognosis
chemical_list: D051272:Glucose Transporter Type 1; C495677:SLC2A1 protein, human